clenbuterol has been researched along with physostigmine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Bryan, J; Cheung, CY; Haggarty, SJ; Healey, D; Kim, S; Kokel, D; Laggner, C; Macrae, CA; Mateus, R; Peterson, RT; Shoichet, B; Werdich, AA; White, R | 1 |
| Baratti, CM; Introini-Collison, IB | 1 |
3 other study(ies) available for clenbuterol and physostigmine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Rapid behavior-based identification of neuroactive small molecules in the zebrafish.
Topics: | 2010 |
Memory-modulatory effects of centrally acting noradrenergic drugs: possible involvement of brain cholinergic mechanisms.
Topics: Animals; Atropine; Atropine Derivatives; Avoidance Learning; Brain; Cholinergic Fibers; Clenbuterol; Male; Mental Recall; Mice; Neostigmine; Oxotremorine; Parasympatholytics; Parasympathomimetics; Physostigmine; Propranolol; Reaction Time; Receptors, Adrenergic; Receptors, Muscarinic; Retention, Psychology | 1992 |